<DOC>
	<DOC>NCT02935725</DOC>
	<brief_summary>A Phase 1, Single-centre, Double-blind, Placebo controlled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants</brief_summary>
	<brief_title>A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Male aged 18 to 45 years, inclusive at Visit 1. Healthy on the basis of medical history, psychiatric history, physical examination, vital signs, 12lead electrocardiogram (ECG), haematology, blood chemistry and urinalysis within 6 weeks of Visit 2. Righthanded. Not a regular smoker (maximum 5 cigarettes per week or equivalent). History of, or current condition of, migraine headaches or has undergone operations to the head. History of significant claustrophobia.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>